BindingDB logo
myBDB logout

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
24411477 84 Carbamazepine derivatives with P2X4 receptor-blocking activity.EBI University of Bonn
20045645 66 Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.EBI Roche Palo Alto
23075067 98 N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists.EBI University of Bonn
12213051 207 Purine and pyrimidine (P2) receptors as drug targets.EBI National Institute of Diabetes
19231180 81 Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.EBI Roche Palo Alto LLC
19231178 61 Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.EBI Roche Palo Alto LLC
11462975 50 Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.EBI National Institute of Diabetes and Digestive and Kidney Diseases
11111828 16 Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications.BDB Biocentre Niederursel
9016352 9 Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue.BDB Max-Planck Institute for Experimental Medicine